Loading clinical trials...
Loading clinical trials...
The objective of this study is to assess the changes in symptoms and cognition that occur after a 28-day abstinence period in patients with comorbid Cannabis Use Disorder (CUD) and Bipolar (Type I or ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre for Addiction and Mental Health
NCT07589647 · Bipolar Disorder (BD)
NCT06226025 · Bipolar Disorder, Delayed Sleep-Wake Phase Disorder
NCT06575751 · Cannabis Use Disorder
NCT06784908 · HIV, Depression, and more
NCT07140913 · Mania, Bipolar Disorder
Centre for Addiction and Mental Health
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions